T. Rowe Price holds 3.02% of Qiagen voting rights

QGEN•2026-11-12

T. Rowe Price Group held 3.02% of Qiagen’s voting rights as of Nov. 3, 2026: 2.78% indirect real voting rights and 0.24% indirect potential voting rights.

1. Voting rights disclosed

Qiagen disclosed that T. Rowe Price Group held 3.02% of its voting rights as of Nov. 3, 2026. The holding comprised 2.78% indirect real voting rights and 0.24% indirect potential voting rights.

T. Rowe Price holds 3.02% of Qiagen voting rights

1. Voting rights disclosed

Related News

Novavax joins Jefferies healthcare conference for fireside chat

Nvidia board reportedly working with outside firm to identify potential replacements for CEO Jensen Huang

Solana Co Q3 revenue beats estimates on SOL staking

MariMed Q3 adjusted EBITDA $4.7 million

Ag Growth International Q3 adjusted EBITDA fell 45% to CAD 39.01 million on Commercial weakness